Does a higher arachidonic acid to EPA ratio promote inflammation, higher ferritin, and increased platelet activation?

An elevated ratio of arachidonic acid (AA) to eicosapentaenoic acid (EPA) and a high omega-6 to omega-3 ratio significantly alter systemic inflammatory and hematological profiles through defined enzymatic and cytokine cascades.

Eicosanoid pathway shifting

• AA and EPA compete directly as substrates for cyclooxygenase (COX) and lipoxygenase (LOX) enzymes.
• When the AA:EPA ratio is elevated, AA dominates the enzymatic active sites, favoring the synthesis of highly potent, pro-inflammatory series-2 prostaglandins (such as PGE2) and series-4 leukotrienes (such as LTB4). EPA acts as a functional competitive inhibitor to shift this balance.

Indirect upregulation of ferritin

• While pro-inflammatory eicosanoids do not directly regulate ferritin, PGE2 stimulates the synthesis and expression of interleukin-6 (IL-6) via EP receptors and downstream NF-kB/PKA/PI3K pathways.
• IL-6 then drives the acute-phase response, promoting ferritin L-subunit translation and FTH1 transcription via STAT3/NF-kB pathways, which raises circulating ferritin levels.

Platelet activation and volume changes

• Pro-inflammatory eicosanoids, particularly thromboxane A2 (TXA2) and lipoxygenase-derived species (12-HETE and 15-HETE), bind to platelet receptors to trigger shape change, granule release, and aggregation.
• Accelerated platelet activation and consumption prompts the bone marrow to release younger, larger, and more metabolically active platelets, increasing Mean Platelet Volume (MPV).
• This response is reinforced because IL-6 modulates megakaryopoiesis to release larger platelets, and these high-MPV platelets contain higher enzymatic capacity to generate even more TXA2.

Bottom line

• An elevated AA:EPA and omega-6:omega-3 ratio shifts enzymatic pathways to favor pro-inflammatory lipid mediators, which indirectly raises ferritin via an IL-6-mediated acute-phase response and accelerates platelet turnover to increase mean platelet volume.